TScan Therapeutics TCRX Balance Sheet (2020-2026)

NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST
Reported Financials

TScan Therapeutics Quarterly Balance Sheet

Periods 26 quarters
Latest Sep 2026
Industry Template General

TScan Therapeutics reported total assets of $0.14B and total liabilities of $0.10B for the quarter ended Sep 2026, down 46.1% year over year. This balance sheet covers 26 quarters of results from Jun 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
161.41M140.84M125.60M137.31M120.03M95.61M208.84M155.19M133.36M140.51M242.16M133.12M178.69M154.11M169.39M169.51M152.41M128.06M100.20M73.04M
Short-term InvestmentsInvestments (Current)
60.23M58.69M22.27M55.52M138.00M111.42M97.58M48.65M14.95M
Cash & Current Investments
161.41M140.84M125.60M137.31M120.03M95.61M208.84M215.42M192.04M162.78M297.68M271.12M290.11M251.69M218.05M184.45M152.41M128.06M100.20M73.04M
Receivables - NetNet Receivables
31.93M
Receivables
31.93M
Prepaid Assets
4.25M4.91M3.76M3.87M4.10M5.30M1.45M2.14M2.19M1.94M1.85M2.97M2.61M3.15M3.09M3.71M4.80M4.71M4.25M3.75M
Current Assets
165.65M145.75M129.36M141.18M124.13M100.91M242.22M217.57M194.24M164.72M299.53M274.09M292.72M254.84M221.13M188.17M157.21M132.77M104.40M76.78M
Non-Current Assets
Construction in Progress
1.26M0.01M0.55M0.10M0.12M
Property, Plant & Equipment (Net)PP&E (Net)
11.77M10.69M10.80M10.33M10.10M9.02M8.21M8.60M7.74M7.20M7.62M7.46M7.24M8.35M9.52M9.30M8.71M8.12M7.74M7.11M
Other Non-Current Assets
5.20M5.03M5.04M5.04M5.76M5.03M5.03M5.03M6.68M5.03M5.03M5.03M6.80M5.03M5.03M5.03M5.13M5.10M5.08M5.11M
Non-Current Assets
22.45M22.46M23.06M24.28M74.96M72.67M74.71M73.81M77.91M76.11M75.34M73.94M78.40M77.87M77.43M74.06M71.58M69.23M67.05M64.62M
Assets
188.11M168.20M152.42M165.45M199.09M173.58M316.92M291.38M272.15M240.83M374.87M348.03M371.12M332.71M298.56M262.23M228.79M201.99M171.45M141.40M
Liabilities
Current Liabilities
Accounts Payables
1.77M2.89M3.10M2.71M2.91M2.77M3.39M3.20M2.37M2.12M3.11M3.65M4.28M4.97M4.54M6.35M1.24M2.30M3.12M1.24M
Payables
1.77M2.89M3.10M2.71M2.91M2.77M3.39M3.20M2.37M2.12M3.11M3.65M4.28M4.97M4.54M6.35M1.24M2.30M3.12M1.24M
Accumulated Expenses
6.52M3.01M4.16M6.16M6.84M7.44M8.30M9.26M10.72M8.79M10.81M11.18M15.41M9.61M12.80M10.77M7.67M8.59M7.83M12.88M
Other Accumulated Expenses
1.01M0.16M0.70M1.29M0.43M0.44M0.43M0.43M0.43M0.26M0.25M0.25M0.08M0.20M0.19M0.19M0.20M0.20M0.19M
Short term Debt
1.11M3.35M6.80M10.34M11.71M15.70M
Current Deferred Revenue
11.41M10.87M8.17M5.93M3.87M19.21M15.21M10.14M10.44M10.70M9.93M11.70M10.27M7.70M5.19M2.62M1.64M0.59M
Total Current Liabilities
21.34M18.47M17.17M16.59M17.31M14.05M35.12M33.15M29.82M31.48M38.57M28.66M35.96M29.82M31.32M29.21M18.70M19.97M30.96M37.82M
Non-Current Liabilities
Non-Current Debt
29.07M29.29M29.50M29.72M28.84M26.70M23.45M20.11M30.65M32.07M32.18M32.30M32.41M32.53M32.65M21.07M17.27M
Non-Current Deferred Revenue
1.50M7.64M7.76M5.62M4.76M3.96M3.68M1.25M0.50M
Preferred Stock Liabilities
Operating Leases
4.39M3.95M3.50M3.03M53.01M51.97M53.81M52.66M59.14M58.18M57.01M55.81M60.74M59.88M58.12M56.30M54.44M52.45M50.40M48.30M
Other Non-Current Liabilities
0.10M0.10M0.10M0.10M0.05M0.04M0.02M0.01M0.15M0.14M0.12M0.11M0.28M73.01M69.81M62.25M
Total Non-Current Liabilities
27.23M22.41M20.67M48.70M99.61M95.52M126.29M122.41M118.79M130.01M122.38M121.73M117.93M32.65M35.26M40.19M
Total Liabilities
27.33M22.51M20.76M48.80M99.66M95.56M126.32M122.42M121.28M117.87M119.65M118.94M130.15M122.51M121.85M118.20M105.67M105.07M102.43M103.39M
Shareholder's Equity
Total Debt
29.07M29.29M29.50M29.72M29.95M30.05M30.25M30.45M30.65M32.07M32.18M32.30M32.41M32.53M32.65M32.78M32.97M
Common Equity
160.78M145.69M131.65M116.66M99.43M78.02M190.61M168.96M150.87M122.97M255.22M229.09M240.97M210.20M176.71M144.02M123.12M96.92M69.02M38.01M
Liabilities and Shareholders Equity
188.11M168.20M152.42M165.45M199.09M173.58M316.92M291.38M272.15M240.83M374.87M348.03M371.12M332.71M298.56M262.23M228.79M201.99M171.45M141.40M
Retained Earnings
-92.16M-108.31M-123.41M-139.70M-158.38M-180.94M-205.00M-228.00M-247.60M-277.74M-309.40M-339.30M-375.10M-409.22M-446.20M-481.90M-504.86M-533.53M-563.90M-597.00M
Treasury Shares
97.76M100,330.30M92.65M

TScan Therapeutics Balance Sheet API

Pull TScan Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TCRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY